Cash Flow from Operating Activities (Quarterly)

Cash Flow from Operating Activities: A company's cash flows from operations.

Astellas Pharma Inc. (ALPMY) had Cash Flow from Operating Activities of $378.38M for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$3.49B
Net Income	$472.11M
Cost of Goods Sold	$654.32M
Gross Profit	$2.84B
Operating Expenses	$2.72B
Operating Income	$770.11M
Non-Operating Income/Expense	$-146.23M
Pre-Tax Income	$623.87M
Normalized Pre-Tax Income	$623.87M
Income after Taxes	$472.11M
Income from Continuous Operations	$472.11M
Consolidated Net Income/Loss	$472.11M
Normalized Income after Taxes	$472.11M
EBIT	$770.11M
EBITDA	$1.10B
Weighted-Average Shares Outstanding (Basic)	1.79B
Weighted-Average Shares Outstanding (Diluted)	1.80B
Earnings per Share (EPS) (Basic)	$0.26
Earnings per Share (EPS) (Diluted)	$0.26
Balance Sheet Financials
Current Assets	$8.92B
Property, Plant, and Equipment	$2.23B
Long-Term Assets	$14.09B
Total Assets	$23.02B
Current Liabilities	$7.64B
Long-Term Debt	$3.85B
Long-Term Liabilities	$5.15B
Total Liabilities	$12.79B
Common Equity	$10.22B
Tangible Shareholders Equity	$293.95M
Shareholders Equity	$10.22B
Common Shares Outstanding	--
Cash Flow Statement Financials
Cash Flow from Operating Activities	$378.38M
Cash Flow from Investing Activities	$-115.54M
Cash Flow from Financial Activities	$-76.19M
Beginning Cash	$1.30B
End Cash	$1.49B
Increase/Decrease in Cash	$186.49M
Stock-Based Compensation	--
Common Stock Dividends Paid	$-457.06M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.17
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.27
Debt to Equity Ratio	0.62
Gross Margin	81.25%
Operating Margin	22.07%
EBIT Margin	22.07%
EBITDA Margin	--
Pre-Tax Profit Margin	17.88%
Profit Margin	13.53%
Free Cash Flow	$290.00M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.15
Inventory Turnover	0.31
Receiveable Turnover	0.74
Days Sales in Receivables	121.19
Return on Equity	4.62%
Return on Tangible Equity	160.61%
Return on Assets	2.05%
Return on Investments	3.35%
Book Value Per Share	--
Free Cash Flow per Share	$0.16
Operating Cash Flow per Share	$0.21

Data from Zacks Investment Research, Inc.